CVS Sues Takeda, Bora Units Claiming Collusion on Reflux Drug

CVS Health Corp. on Tuesday sued Takeda Pharmaceutical Co. Ltd. and other drugmakers with antitrust claims that they delayed the generic version of a blockbuster drug to treat gastroesophageal reflux.

CVS’ complaint mirrors a suit brought in March against Takeda by several other retailers including Walgreen Co., Kroger Co., and Albertsons Cos.

CVS and the other retailers are represented by the same firm, Sperling Kenny Nachwalter LLC.

Takeda is among a string of pharmaceutical companies targeted in “pay-for-delay” lawsuits, in which brand-name companies are accused of paying a generic drug company to delay launching the cheaper version of ...